Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
32.3M
-
Shares change
-
+11.6M
-
Total reported value, excl. options
-
$479M
-
Value change
-
+$173M
-
Put/Call ratio
-
0.22
-
Number of buys
-
73
-
Number of sells
-
-21
-
Price
-
$14.82
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2020
115 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q2 2020.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.3M shares
of 86.6M outstanding shares and own 37.31% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.76M shares), BVF INC/IL (2.47M shares), BOXER CAPITAL, LLC (2.29M shares), MPM ASSET MANAGEMENT LLC (2.17M shares), BlackRock Inc. (2.14M shares), Avidity Partners Management LP (1.53M shares), VANGUARD GROUP INC (1.43M shares), FRAZIER MANAGEMENT LLC (1.32M shares), ORBIMED ADVISORS LLC (1.09M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.05M shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.